Logos Global Management LP I Teos Therapeutics, Inc. Transaction History

Logos Global Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$30.86 - $44.2 $3.09 Million - $4.42 Million	-100,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$21.59 - $33.95 $4.32 Million - $6.79 Million	-200,000 Reduced 66.67%	100,000 $3.38 Million
Q3 2020 Nov 16, 2020	BUY	$17.57 - $32.92 $5.27 Million - $9.88 Million	300,000 New	300,000 $7.4 Million

151

36.4M

653K

1.48M

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $330M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.